Recursion Pharmaceuticals (RXRX) Depreciation & Amortization (CF) (2020 - 2026)
Recursion Pharmaceuticals' Depreciation & Amortization (CF) came in at $18.17 million for Q2 2026, down 23.8% from $23.85 million a year earlier and down 7.7% from the prior quarter.
Powered by 
Analysis
Recursion Pharmaceuticals (RXRX) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Recursion Pharmaceuticals reported Depreciation & Amortization (CF) of $78.36 million, up 23.7% year-over-year; for FY2025, it came in at $83.7 million, up 129.4% from FY2024.
- Depreciation & Amortization (CF) has increased in each of the last six years, with a five-year compound annual growth rate of 84.2% (FY2020 to FY2025).
- Going back by year, Depreciation & Amortization (CF) was $36.49 million in FY2024 (+49.6%), $24.4 million in FY2023 (+107.6%), $11.76 million in FY2022 (+39.9%) and $8.41 million in FY2021 (+113.2%).
- The Q2 2026 figure represents the lowest quarterly Depreciation & Amortization (CF) since Q4 2024.
- Year-over-year, Depreciation & Amortization (CF) increased in six of the last eight quarters, with growth averaging 76.9%.
- The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q3 2025 (growth of 192.3%), and the weakest in Q2 2026 (a decline of 23.8%).
- Business Quant data shows RXRX's Depreciation & Amortization (CF) at $19.67 million (Q1 2026), $19.48 million (Q4 2025) and $21.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.96 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 194.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 599.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.93 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.11 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 98.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.62 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 56.50 Mn |
| 10 | Recursion Pharmaceuticals | 2.21 Bn | -397.37 Mn | -3.82 Mn | 18.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.17 Mn |
| Mar 31, 2026 | 19.67 Mn |
| Dec 31, 2025 | 19.48 Mn |
| Sep 30, 2025 | 21.04 Mn |
| Jun 30, 2025 | 23.85 Mn |
| Mar 31, 2025 | 19.33 Mn |
| Dec 31, 2024 | 12.95 Mn |
| Sep 30, 2024 | 7.20 Mn |
| Jun 30, 2024 | 8.97 Mn |
| Mar 31, 2024 | 7.38 Mn |
| Dec 31, 2023 | 7.55 Mn |
| Sep 30, 2023 | 7.58 Mn |
| Jun 30, 2023 | 5.54 Mn |
| Mar 31, 2023 | 3.73 Mn |
| Dec 31, 2022 | 3.21 Mn |
| Sep 30, 2022 | 2.99 Mn |
| Jun 30, 2022 | 2.79 Mn |
| Mar 31, 2022 | 2.77 Mn |
| Dec 31, 2021 | 2.24 Mn |
| Sep 30, 2021 | 2.44 Mn |
API Access
Recursion Pharmaceuticals Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RXRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "RXRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=RXRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();